These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Silencing of homeobox B9 is associated with down-regulation of CD56 and extrathyroidal extension of tumor in papillary thyroid carcinoma. Kim JH; Kim YH; Han JH; Lee KB; Sheen SS; Lee J; Soh EY; Park TJ Hum Pathol; 2012 Aug; 43(8):1221-8. PubMed ID: 22225776 [TBL] [Abstract][Full Text] [Related]
43. Primary mucoepidermoid carcinoma and sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid gland: a report of nine cases. Baloch ZW; Solomon AC; LiVolsi VA Mod Pathol; 2000 Jul; 13(7):802-7. PubMed ID: 10912941 [TBL] [Abstract][Full Text] [Related]
44. Expression of syndecan-1 in papillary carcinoma of the thyroid with extracapsular invasion. Bologna-Molina R; González-González R; Mosqueda-Taylor A; Molina-Frechero N; Damián-Matsumura P; Dominguez-Malagón H Arch Med Res; 2010 Jan; 41(1):33-7. PubMed ID: 20430252 [TBL] [Abstract][Full Text] [Related]
45. Morules in cribriform-morular variant of papillary thyroid carcinoma: Immunohistochemical characteristics and distinction from squamous metaplasia. Hirokawa M; Kuma S; Miyauchi A; Qian ZR; Nakasono M; Sano T; Kakudo K APMIS; 2004; 112(4-5):275-82. PubMed ID: 15233643 [TBL] [Abstract][Full Text] [Related]
46. Incidence and significance of clinically unsuspected thyroid tissue in lymph nodes found during neck dissection in head and neck carcinoma patients. León X; Sancho FJ; García J; Sañudo JR; Orús C; Quer M Laryngoscope; 2005 Mar; 115(3):470-4. PubMed ID: 15744160 [TBL] [Abstract][Full Text] [Related]
47. Immunohistochemical characteristics of diffuse sclerosing variant of papillary carcinoma: comparison with conventional papillary carcinoma. Koo JS; Shin E; Hong SW APMIS; 2010 Oct; 118(10):744-52. PubMed ID: 20854468 [TBL] [Abstract][Full Text] [Related]
48. Immunohistochemical analysis of expression of bcl-2 protein in papillary carcinomas and papillary microcarcinomas of the thyroid gland. Mitselou A; Peschos D; Dallas P; Charalabopoulos K; Agnantis NJ; Vougiouklakis T Exp Oncol; 2004 Dec; 26(4):282-6. PubMed ID: 15627060 [TBL] [Abstract][Full Text] [Related]
50. [Differentiated thyroid gland carcinoma in children and adolescents]. Meller J; Conrad M; Behr T; Gratz S; Becker W Klin Padiatr; 1998; 210(5):373-8. PubMed ID: 9782484 [TBL] [Abstract][Full Text] [Related]
51. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446 [TBL] [Abstract][Full Text] [Related]
52. Survival of aggressive variants of papillary thyroid carcinoma in patients under 55 years old: a SEER population-based retrospective analysis. Feng J; Shen F; Cai W; Gan X; Deng X; Xu B Endocrine; 2018 Sep; 61(3):499-505. PubMed ID: 29909599 [TBL] [Abstract][Full Text] [Related]
53. Diffuse sclerosing variant of papillary thyroid carcinoma. Clinicopathologic study of 15 cases. Carcangiu ML; Bianchi S Am J Surg Pathol; 1989 Dec; 13(12):1041-9. PubMed ID: 2490923 [TBL] [Abstract][Full Text] [Related]
54. Diffuse sclerosing variant of papillary thyroid carcinoma. Macák J; Michal M Cesk Patol; 1993 Feb; 29(1):6-8. PubMed ID: 8485781 [TBL] [Abstract][Full Text] [Related]
55. Diffuse sclerosing variant of papillary thyroid carcinoma. S-100 protein immunocytochemistry and prognosis. Schröder S; Bay V; Dumke K; Kremens B; Müller-Gärtner HW; Böcker W; Kastendieck H Virchows Arch A Pathol Anat Histopathol; 1990; 416(4):367-71. PubMed ID: 2106754 [TBL] [Abstract][Full Text] [Related]
56. Estrogen receptor- and progesterone receptor-positive diffuse sclerosing variant of papillary thyroid carcinoma: a case report. Kinoshita Y; Takasu K; Yuri T; Yoshizawa K; Emoto Y; Tsubura A; Shikata N Case Rep Oncol; 2013 Jan; 6(1):216-23. PubMed ID: 23626564 [TBL] [Abstract][Full Text] [Related]
58. Diffuse sclerosing variant of papillary carcinoma of the thyroid: a histological and immunohistochemical study of three cases. Chan JK; Tsui MS; Tse CH Histopathology; 1987 Feb; 11(2):191-201. PubMed ID: 2437003 [TBL] [Abstract][Full Text] [Related]
60. Relationship between recurrence and age in the diffuse sclerosing variant of papillary thyroid carcinoma: clinical significance in pediatric patients. Kim J; Koo JS; Bang JI; Kim JK; Kang SW; Jeong JJ; Nam KH; Chung WY Front Endocrinol (Lausanne); 2024; 15():1359875. PubMed ID: 38966212 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]